Welcome: Guest | Site Use Options | Register | Login |

Janssen Biotech Inc

800 Ridgeview Drive
Horsham, PA 19044
 Synopsis: Business Condition
Year Founded 1979
Employment 1,001
Sector N/A
Industry Pharmaceuticals & Biotech Pharmaceuticals - Diversified (Primary)
Janssen Biotech Inc
     Last modified on: 3/19/14

Janssen Biotech, Inc. develops and markets solutions for oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Its products include REMICADE (infliximab) for patients to treat plaque psoriasis, rheumatoid and psoriatic arthritis, Crohn's and pediatric Crohn's disease, ankylosing spondylitis, and ulcerative and pediatric ulcerative colitis; STELARA, a prescription medicine to treat adults 18 years and older with moderate or severe plaque psoriasis; and SIMPONI(golimumab), a once-monthly self-injectable biologic treatment for adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis. The company's products also include PROCRIT Epoetin alfa) for the treatment of anemia due to chronic kidney disease, zidovudine in HIV-infected patients, and chemotherapy in patients with cancer; and reduction of allogeneic red blood cell transfusions in patients undergoing elective, noncardiac, and nonvascular surgery. In addition, its products include DOXIL (doxorubicin HCl liposome injection) to treat patients with ovarian cancer; and ZYTIGA (abiraterone acetate), a prescription medicine that is used along with prednisone to treat men with castration-resistant prostate cancer that has spread to other parts of the body. It serves healthcare professionals and patients in the United States. Janssen Biotech, Inc. was formerly known as Centocor Ortho Biotech, Inc. and changed its name to Janssen Biotech, Inc. in June 2011. The company was founded in 1979 and is based in Horsham, Pennsylvania. As of October 6, 1999, Janssen Biotech, Inc. operates as a subsidiary of Johnson & Johnson.


Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920